南微醫學(688029.SH):對已集中隔離的密切接觸者及其他1736名在寧員工的第二次核酸檢測 結果均為陰性
格隆匯 1 月 10日丨南微醫學(688029.SH)公佈,2021年1月6日,公司發生進口原材料倉庫送檢地面樣本新冠病毒核酸檢測陽性事件。事件發生後,公司於2021年1月7日完成工作人員及家屬共3067人的全員核酸採樣檢測工作,檢測結果均為陰性。關於該事件詳情請見公司於2021年1月8日披露的《南微醫學科技股份有限公司關於重大事件情況説明暨復牌公吿》(公吿編號2021-002)。
根據政府相關部門要求,公司組織對全體在寧員工進行第二次集中採樣核酸檢測,二次檢測結果無異常後方可正常工作生活。2021年1月8日,公司完成對已集中隔離的密切接觸者及其他1736名在寧員工的第二次核酸檢測,檢測結果均為陰性。
目前,公司正配合政府部門對工作環境進行全面消殺。同時,已完善相關制度,落實對發出的產品進行實時包裝物核酸檢測、隨貨附核酸檢測報吿,保證送到客户手中的產品絕對安全。後續,公司將繼續嚴格貫徹政府防控部署,嚴防死守,強化執行相關防控措施,並堅決落實政府相關部門整改要求,在確保安全的前提下,逐步有序全面恢復生產經營。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.